The shift toward steering appropriate cardiovascular cases to outpatient settings is gaining momentum, driven by a series of new rules from the Centers for Medicare & Medicaid Services (CMS). Earlier ...
Sept. 15, 2026 — The Food & Drug Administration has approved Abbott’s AVEIR VR Mini Ventricular leadless pacemaker (LP) ...
Sept. 14, 2026 — Interventional Medical Device Solutions (IMDS), has announced the U.S. launch of NHanceIT, an over-the ...
Sept. 8, 2026 — Penumbra recently launched the Link clot capture device designed to support the removal of arterial ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
The shift toward steering appropriate cardiovascular cases to outpatient settings is gaining momentum, driven by a ...
Sept. 9, 2026— Atman Health has been selected by the Advanced Research Projects Agency for Health (ARPA-H) to develop an ...
Sept. 9, 2026 —The Nicklaus Children's Hospital Heart Institute has successfully performed one of the first Fontan ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
Aug. 29, 2026— Vesalio recently announced results from the NATURE trial (NCT04969471), a prospective, randomized ...
Sept. 8, 2026 — New research1 indicates that people with invasive cancer face an elevated risk of experiencing a stroke ...
Aug. 27, 2026 — Artificial intelligence is fundamentally reshaping the cardiovascular devices landscape, driven by a ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Sept. 8, 2026 — Abbot has announced that it has received U.S. Food and Drug Administration (FDA) approval for the ...
Sept. 2, 2026 — Heartvue.ai and Innolitics have announced the U.S. Food and Drug Administration has granted 510(k) ...
Aug. 31, 2026 — Caristo Diagnostics has announced new independent University of Oxford-led research showing that Caristo ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Aug. 31, 2026 — Amgen has announced new findings showing Repatha (evolocumab) reduced the risk of death in high-risk ...
Aug. 30, 2026 — Bayer has announced the presentation of first detailed results from the Phase III REVEAL study, an ...
Aug. 31, 2026 — At the European Society of Cardiology Congress in Munich, Abbott announced new late-breaking 12-month ...
September 16, 2026
